Digital Clinical Outcomes Assessments and Digital Biomarkers: They are not the same and we need research on both

  • 2,723

    Total downloads

  • 11k

    Total views and downloads

Submit your idea

You will be redirected to our submission process.

Submit your manuscript summarySubmit your manuscript

About this Research Topic

Submission closed

Background

In 2018 and 2019, the JP Morgan Healthcare Conference in San Francisco and the Consumer Electronics Show in Las Vegas were convened on overlapping dates, but since 2020 the two conferences have been held in succession (with the exception of 2021 covid 19-related adjustments). This shift in convening dates likely reflects the rapid conversion of consumer electronics into healthcare applications and the morphing of two different audiences into the same one. In the development of its Digital Health Innovation Plan1 and the establishment of its Digital Health Center of Excellence,2 the Food and Drug Administration (FDA) has also recognized the opportunity hardware, software and analytic advances offer in shaping the future of healthcare.

In the arena of neurodegenerative disorders, many decades of research have started to give way to successive readouts on Alzheimer’s disease (AD),3 lewy body dementia (LBD)4 and amyotrophic lateral sclerosis (ALS)5 clinical trial results and increased clinical trials in frontotemporal dementia (FTD)6,7; all of which suggest we are on the cusp of effective disease modifying treatments for AD and other related dementias (ADRD). But one persistent challenge is accurate clinically meaningful outcome measurements, the expression of which is mediated by a myriad of factors and thus, are highly heterogeneous at the time of study measurement. The continued reliance on current FDA-approved legacy outcomes, which were all defined and validated using old methodologies and instruments has attenuated the promise of digital technologies in this field of research and care.

The race to find digital substitutes has also produced a new challenge. Misuse of the term “digital biomarkers” is rampant where any metric collected using a digital device or application is defined as such. The FDA has tried to clarify the difference between a clinical outcomes assessment (COA) and a digital biomarker; their position has been reinforced by others as well (Au et al, 2022; Hampel et al., 2022).9,10 Currently, most functional outcomes (e.g., gait, step counts, sleep, speech) obtained through digital devices are not specific to a certain etiology. They can decline due to many things other than cognition. Walking speed, for example, can lead to slowdowns due to joint pain or Parkinson’s disease (PD). Speech characteristics might change due to primary progressive aphasia (PPA), vascular dementia (VD) or AD. Cognitive or functional changes could also result from perioperative events. Digital biomarkers, on the other hand, are in the words of the FDA “a characteristic or set of characteristics, collected from digital health technologies, that is measured as an indicator of normal biological processes, pathogenic processes, or responses to an exposure or intervention, including therapeutic interventions.” Digital biomarkers require the same rigorous scientific investigation used to identify and validate biomarkers from blood, urine, cerebrospinal fluid and imaging and much research lies ahead to determined digital biomarkers that are specific to etiology and can meet FDA approval.

We are still in the nascent stage of the digital era and there is great clinical value in both digital COA and digital biomarkers that apply to brain related outcomes (cognitive, function, behavior, diagnosis). The purpose of this special issue is to invite papers that highlight both. For example, we welcome papers that illustrate specificity of digital COA in differentiating ADRDs (e.g., AD, FTD, LBD, vascular dementia, primary progressive aphasia, etc). We also welcome papers that are seeking to define and validate digital biomarkers, including those that test new methods and approaches and may be the first to set a precedent in which there is no prior published literature. Further, the added advantage of digital COA and biomarkers is their capacity to provide highly frequently monitored data which could transform how we run clinical trials including the duration of follow-up and required sample size. Therefore, we also welcome analytical innovations in this regard. We encourage submissions that are not bounded by the past or present and will add to the foundation of a future whose richness is still to be determined.

Keywords: Digital clinical outcome assessments (COA), digital biomarkers, Alzheimer’s disease and related disorders, digital technology, analytic innovations

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Topic editors

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

    In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

     

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

     

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.

     

Impact

  • 11kTopic views
  • 7,998Article views
  • 2,723Article downloads
View impact